• Inhibits coinhibitory checkpoint molecule LAG-2 on activated T cells preventing binding to MHC-II on DCs, pDC and melanoma cells• Enhances T-eff and myeloid cell responses (DCs, macrophages and NK cells. This evidence concerns the gene GNLY and melanoma.